StonvexLoading…
StonvexCore line items from SUI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 |
|---|---|---|---|---|---|
Revenue | $640.45M | $967.60M | $441.40M | $1.90B | $1.46B |
Operating Income | Not available | Not available | Not available | Not available | $301.60M |
Net Income | Not available | $-210.20M | $-43.70M | $261.40M | $237.30M |
EPS (Diluted) | $0.73 | $-2.04 | $-0.36 | $2.00 | $1.32 |
Total Assets | Not available | $17.23B | $17.35B | $17.08B | $16.48B |
Total Liabilities | Not available | $9.47B | $9.29B | $8.99B | $8.35B |
Cash & Equivalents | Not available | $68.70M | $74.80M | $72.80M | $112.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-186.10M | Not available |
Shares Outstanding | Not available | 124.40M | 124.42M | 124.00M | 123.88M |